PRVB
Provention Bio, Inc. Common Stock
PRVB
PRVB
Delisted
PRVB was delisted on the 26th of April, 2023.
112 hedge funds and large institutions have $187M invested in Provention Bio, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 51 increasing their positions, 18 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
21% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 14
Holders
112
Holding in Top 10
1
Calls
$4.45M
Puts
$1.21M
Top Buyers
| 1 | +$40M | |
| 2 | +$21.9M | |
| 3 | +$4.62M | |
| 4 |
BlackRock
New York
|
+$1.91M |
| 5 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$1.76M |
Top Sellers
| 1 | -$610K | |
| 2 | -$555K | |
| 3 | -$524K | |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
-$420K |
| 5 |
JF
Jump Financial
Chicago,
Illinois
|
-$222K |